• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Bial - Articles and news items

EMA accepts submission for Zebinix use as a monotherapy for partial-onset seizures

EMA accepts submission for Zebinix use as a monotherapy for partial-onset seizures

Industry news / 17 May 2016 / Katie Sadler

The European Medicines Agency (EMA) has accepted Bial’s submission for once-daily epilepsy treatment Zebinix as monotherapy for partial-onset seizures.

clinical trial

Man dies after taking part in Phase I clinical trial

Industry news / 18 January 2016 / Victoria White

In a statement, The University Hospital of Rennes confirmed that five other participants in the clinical trial remain in a stable condition…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +